Durvalumab With or Without Metformin in Treating Participants With Head and Neck Squamous Cell Carcinoma
Conditions: Larynx; Lip, Oral Cavity and Pharynx Interventions: Drug: Metformin; Biological: Durvalumab Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 7, 2018 Category: Research Source Type: clinical trials
Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT
Conditions: Malignant Neoplasm of Breast; Malignant Neoplasms of Digestive Organs; Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System; Malignant Neoplasms of Female Genital Organs; Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites; Malignan t Neoplasms of Independent (Primary) Multiple Sites; Malignant Neoplasms of Lip Oral Cavity and Pharynx; Malignant Neoplasms of Male Genital Organs; Malignant Neoplasms of Mesothelial and Soft Tissue; Malignant Neoplasms of Respiratory and Intrathoracic Organs; Malignant Neoplasm s of Thyroid and ...
Source: ClinicalTrials.gov - February 16, 2018 Category: Research Source Type: clinical trials
